Essential Site Maintenance: Authorea-powered sites will be updated circa 15:00-17:00 Eastern on Tuesday 5 November.
There should be no interruption to normal services, but please contact us at [email protected] in case you face any issues.

loading page

The potential of extracellular vesicle lipid profiling in Alzheimer's disease.
  • +3
  • Huaqi Su,
  • Colin Masters,
  • Ashley Bush,
  • Kevin Barnham,
  • Gavin Reid,
  • Laura Vella
Huaqi Su
The University of Melbourne
Author Profile
Colin Masters
The University of Melbourne
Author Profile
Ashley Bush
The University of Melbourne
Author Profile
Kevin Barnham
The University of Melbourne
Author Profile
Gavin Reid
The University of Melbourne
Author Profile
Laura Vella
The University of Melbourne

Corresponding Author:[email protected]

Author Profile

Abstract

Over the past two decades, there has been increasing research into the molecular composition and function of small extracellular vesicles in the central nervous system. This is due in part to the recognition that small extracellular vesicles likely contribute to the pathogenesis of neurological diseases such as Alzheimer's disease, but also an understanding that small extracellular vesicles are a source of potential biomarkers. Small extracellular vesicles carry specific cargo that reflects their biogenesis and cellular origins, including protein, RNA and lipid. While the protein and RNA content of small extracellular vesicles in the central nervous system diseases and have been studied extensively, our understanding of the lipidome of small extracellular vesicles in the central nervous system is still in its infancy. Lipids play a significant role in maintaining central nervous system structure and function, and the dysregulation of lipid metabolism is known to occur in many neurological disorders, including Alzheimer's disease. Here we review what is currently known about lipid dyshomeostasis in Alzheimer's disease. We propose that small extracellular vesicle lipids may provide insight into the pathophysiology and progression of Alzheimer's disease and other neurological disorders, and, in the future perhaps, aid in disease monitoring and detection.
12 May 2023Submitted to PROTEOMICS
12 May 2023Submission Checks Completed
12 May 2023Assigned to Editor
12 May 2023Review(s) Completed, Editorial Evaluation Pending
12 May 2023Reviewer(s) Assigned
30 Jun 2023Editorial Decision: Revise Minor
08 Aug 2023Review(s) Completed, Editorial Evaluation Pending
08 Aug 20231st Revision Received
10 Aug 2023Reviewer(s) Assigned
14 Aug 2023Editorial Decision: Accept